Literature DB >> 20797503

Coronary stents: looking forward.

Scot Garg1, Patrick W Serruys.   

Abstract

Despite all the benefits of drug-eluting stents (DES), concerns have been raised over their long-term safety, with particular reference to stent thrombosis. In an effort to address these concerns, newer stents have been developed that include: DES with biodegradable polymers, DES that are polymer free, stents with novel coatings, and completely biodegradable stents. Many of these stents are currently undergoing pre-clinical and clinical trials; however, early results seem promising. This paper reviews the current status of this new technology, together with other new coronary devices such as bifurcation stents and drug-eluting balloons, as efforts continue to design the ideal coronary stent. Copyright 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20797503     DOI: 10.1016/j.jacc.2010.06.008

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  46 in total

1.  Low-dose sirolimus-eluting hydroxyapatite coating on stents does not increase platelet activation and adhesion ex vivo.

Authors:  Carlos L Alviar; Armando Tellez; Michael Wang; Pamela Potts; Doug Smith; Manus Tsui; Wladyslaw Budzynski; Albert E Raizner; Neal S Kleiman; Eli I Lev; Juan F Granada; Greg L Kaluza
Journal:  J Thromb Thrombolysis       Date:  2012-07       Impact factor: 2.300

Review 2.  Restenosis after PCI. Part 2: prevention and therapy.

Authors:  J Wouter Jukema; Tarek A N Ahmed; Jeffrey J W Verschuren; Paul H A Quax
Journal:  Nat Rev Cardiol       Date:  2011-10-11       Impact factor: 32.419

Review 3.  Progress in material design for biomedical applications.

Authors:  Mark W Tibbitt; Christopher B Rodell; Jason A Burdick; Kristi S Anseth
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-24       Impact factor: 11.205

4.  Accelerated endothelialization with a polymer-free sirolimus-eluting antibody-coated stent.

Authors:  Zhanjiang Yu; Huagang Zhu; Shuzheng Lü; Xiaoda Yang
Journal:  J Mater Sci Mater Med       Date:  2013-08-23       Impact factor: 3.896

5.  Enhanced human endothelial progenitor cell adhesion and differentiation by a bioinspired multifunctional nanomatrix.

Authors:  Adinarayana Andukuri; Young-Doug Sohn; Chidinma P Anakwenze; Dong-Jin Lim; Brigitta C Brott; Young-Sup Yoon; Ho-Wook Jun
Journal:  Tissue Eng Part C Methods       Date:  2012-12-19       Impact factor: 3.056

6.  Enhanced drug delivery capabilities from stents coated with absorbable polymer and crystalline drug.

Authors:  Wenda C Carlyle; James B McClain; Abraham R Tzafriri; Lynn Bailey; Brett G Zani; Peter M Markham; James R L Stanley; Elazer R Edelman
Journal:  J Control Release       Date:  2012-07-16       Impact factor: 9.776

7.  Therapy in ST-elevation myocardial infarction: reperfusion strategies, pharmacology and stent selection.

Authors:  Vikas Singh; Mauricio G Cohen
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-05

8.  Direct Adsorption of Anti-CD34 Antibodies on the Nano-Porous Stent Surface to Enhance Endothelialization.

Authors:  Guowei Fu; Zhanjiang Yu; Yongqiang Chen; Yundai Chen; Feng Tian; Xiaoda Yang
Journal:  Acta Cardiol Sin       Date:  2016-05       Impact factor: 2.672

9.  Bioresorbable Scaffolds.

Authors:  Sidakpal Panaich; Theodore Schreiber; Cindy Grines
Journal:  Interv Cardiol       Date:  2014-08

Review 10.  Biodegradable Metals for Cardiovascular Stents: from Clinical Concerns to Recent Zn-Alloys.

Authors:  Patrick K Bowen; Emily R Shearier; Shan Zhao; Roger J Guillory; Feng Zhao; Jeremy Goldman; Jaroslaw W Drelich
Journal:  Adv Healthc Mater       Date:  2016-04-20       Impact factor: 9.933

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.